Similarly, the number of infiltrating CD86+ cells, which is a biomarker for DCs [40], was dramatically reduced in the mouse group KLN205OV−L1−FGGY (Fig. 7E-F), consistent with the results of cell type analysis in human tumor tissues by IO360. This evidence concerns the gene CD86 and neoplasm.